Activin and Inhibin

AG-270 is an allosteric, noncompetitive, first-in-class, reversible and orally active MAT2A inhibitor, with an IC 50 of 14 nMIn VitroAG-270 demonstrates potent reduction in levels of intracellular SAM , as well as MTAP-–selective antiproliferative

AG-270 is an allosteric, noncompetitive, first-in-class, reversible and orally active MAT2A inhibitor, with an IC 50 of 14 nMIn VitroAG-270 demonstrates potent reduction in levels of intracellular SAM , as well as MTAP-–selective antiproliferative

AG-270 is an allosteric, noncompetitive, first-in-class, reversible and orally active MAT2A inhibitor, with an IC 50 of 14 nMIn VitroAG-270 demonstrates potent reduction in levels of intracellular SAM , as well as MTAP-–selective antiproliferative

AG-270 is an allosteric, noncompetitive, first-in-class, reversible and orally active MAT2A inhibitor, with an IC 50 of 14 nMIn VitroAG-270 demonstrates potent reduction in levels of intracellular SAM , as well as MTAP-–selective antiproliferative

Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC 50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention.In

Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC 50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention.In

Aganepag isopropyl (AGN-210961) is an EP2 agonistIn VitroAganepag isopropyl (AGN-210961) is an EP2 agonist . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:OilIC50&amp: Target:EP2.

Aganepag isopropyl (AGN-210961) is an EP2 agonistIn VitroAganepag isopropyl (AGN-210961) is an EP2 agonist . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:OilIC50&amp: Target:EP2.

AGI-24512 is a potent methionine adenosyltransferase 2α ( MAT2A ) inhibitor, with an IC 50 of 8 nM. AGI-24512 triggers DNA damage response. AGI-24512 can block proliferation of MTAP-deleted cancer cells in vitro . AGI-24512 can be used for

AGI-24512 is a potent methionine adenosyltransferase 2α ( MAT2A ) inhibitor, with an IC 50 of 8 nM. AGI-24512 triggers DNA damage response. AGI-24512 can block proliferation of MTAP-deleted cancer cells in vitro . AGI-24512 can be used for

AGI-24512 is a potent methionine adenosyltransferase 2α ( MAT2A ) inhibitor, with an IC 50 of 8 nM. AGI-24512 triggers DNA damage response. AGI-24512 can block proliferation of MTAP-deleted cancer cells in vitro . AGI-24512 can be used for

AGI-24512 is a potent methionine adenosyltransferase 2α ( MAT2A ) inhibitor, with an IC 50 of 8 nM. AGI-24512 triggers DNA damage response. AGI-24512 can block proliferation of MTAP-deleted cancer cells in vitro . AGI-24512 can be used for